查詢結果分析
相關文獻
- A Validated HPLC Method for the Simultaneous Determination of Vincamine and Its Potential Degradant (Metabolite), Vincaminic Acid: Applications to Pharmaceutical Formulations and Pharmacokinetic Studies
- HPLC分析法在中草藥質量鑑定及其方法建立之進行模式
- 川芎 於大白鼠腦部各區之濃度分佈研究
- 茶葉及咖啡中咖啡因之含量分析
- 中藥方劑之品質管制(4)
- 市售柚類果實、果汁、及柚糖中柚皮苷之含量分析
- 川芎與鬱金所含川芎嗪之高效液相層析定量分析
- 利用高效液相層析法分析定量Quinolone類抗菌劑
- 高效液相層析法對雞肉與豬肉中殘留Quinolone類抗菌劑之檢測
- 中藥材品質調查(2)
頁籤選單縮合
題 名 | A Validated HPLC Method for the Simultaneous Determination of Vincamine and Its Potential Degradant (Metabolite), Vincaminic Acid: Applications to Pharmaceutical Formulations and Pharmacokinetic Studies=經確效之高效液相層析法同時測定長春胺及其潛在降解(代謝)物Vincaminic Acid |
---|---|
作 者 | Sabry, Suzy Mohammed; Belal, Tarek Saied; Barary, Magda Hamdy; Mohammed Elsayed Abdel-Latif Ibrahim; | 書刊名 | Journal of Food and Drug Analysis |
卷 期 | 18:6 2010.12[民99.12] |
頁 次 | 頁447-457+474 |
分類號 | 412.36 |
關鍵詞 | 高效液相層析法; 長春胺; 穩定性試驗; 人體血漿/尿液檢測; HPLC; Vincamine; Vincaminic acid; Stability-indicating assay; In-vivo plasma/urine assays; |
語 文 | 英文(English) |
中文摘要 | 開發並確效可同時測定長春胺及其潛在降解 (代謝) 物 vincaminic acid之高效液相層析法。層析使用 Spheri-5 RP-C8管柱 ( 5 µm,內徑 220 × 4.6 mm),乙腈及 0.05 M醋酸鈉 30:70 (v/v) 為移動相, pH值 4.0,流速 1 mL/min,檢測波長 270 nm,依據波峰面積定量分析物。長春胺和 vincaminic acid濃度範圍分別為 0.1-50和 0.4-50 µg/mL時,呈線性關係。長春胺和 vincaminic acid之偵測極限分別為 0.03和 0.08 µg/mL。本研究目標有二,首先是長春胺於製劑中之穩定性試驗,此外, vincaminic acid的測定可低至同時存在的長春胺之 0.07%。其次是研究口服 60 mg長春胺之健康志願者血漿及尿液樣本,長春胺及其主要代謝物 vincaminic acid之監測。本方法具令人滿意之準確性 (回收率 > 97%),總體標準差介於 1.4至 2.3%。 |
英文摘要 | A sensitive and specific HPLC method was developed and validated for the simultaneous determination of vincamine and its potential degradant (metabolite), vincaminic acid. Chromatographic separation was achieved on a Spheri-5 RP-C8 (5 μm) (220 × 4.6 mm i.d.) column using a mobile phase composed of acetonitrile and 0.05 M sodium acetate, pH 4.0 (30 : 70, v/v) at a flow rate of 1 mL/min. The UV detector was set at 270 nm and the quantitation of the analytes was based on the peak areas. The method was proven to be accurate and precise with linearity ranges of 0.1 -50 and 0.4 -50 µg/mL for vincamine and vincaminic acid, respectively. The limits of detection were 0.03 and 0.08 µg/mL for vincamine and vincaminic acid, respectively. The method was applied to serve two goals. First; stability-indicating assay of vincamine in its pharmaceutical formulations, in addition, the determination of vincaminic acid down to a level of 0.07% in presence of excess of the parent drug. Second; drug monitoring of vincamine and its main metabolite, vincaminic acid in human plasma/urine samples taken from a healthy volunteer treated with 60 mg oral dose of vincamine. The accuracy of the method was satisfactory (recovery > 97%). The overall standard deviation ranged from 1.4 to 2.3%. |
本系統中英文摘要資訊取自各篇刊載內容。